R Forgan-Smith, G A Ellard, D Newton, D A Mitchison. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultBlood-Brain BarrierHumansIsoniazid/therapeutic useMalePyrazinamide/therapeutic useRifampin/therapeutic useStreptomycin/therapeutic useTuberculosis, Meningeal/drug therapy
Substances: See more » PyrazinamideIsoniazidRifampinStreptomycin
Year: 1973 PMID: 4124541 DOI: 10.1016/s0140-6736(73)93211-x
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321